10.6084/m9.figshare.c.3783296_D1.v1 Akinori Yamaguchi Akinori Yamaguchi Makoto Harada Makoto Harada Yosuke Yamada Yosuke Yamada Koji Hashimoto Koji Hashimoto Yuji Kamijo Yuji Kamijo Additional file 1: Table S1. of Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study Springer Nature 2017 Chronic kidney disease Febuxostat Hyperuremia Uric acid Vascular risk factors 2017-05-18 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Identification_of_chronic_kidney_disease_patient_characteristics_influencing_the_renoprotective_effects_of_febuxostat_therapy_a_retrospective_follow-up_study/5023652 Adverse events. There were 15 cases wherein febuxostat treatment was discontinued owing to various adverse events. In most patients, the adverse events developed during the initial dosing of febuxostat at 10 mg/day. (DOCX 18 kb)